Stealth secured a new agency review of its experimental therapy elamipretide after a rejection this year. The result could ...

In people with diabetes and obesity, orforglipron led to weight loss near what people without diabetes experienced in prior ...

Cemdisiran helped control symptoms of generalized myasthenia gravis, but combination treatment with a Regeneron antibody didn ...